Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buqitongluo Granule for Qi Deficiency and Blood Stasis Syndrome
NCT04408261Phase 2Unknown
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Jul 2020
- Primary completion
- Dec 2022
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 2 trial of Buqitongluo Granule in ischemic stroke, stable angina pectoris, diabetic peripheral neuropathy (DPN), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Status: unknown.
02
Drugs
Buqitongluo Granule
03
Conditions
ischemic strokestable angina pectorisdiabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT04408261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04408261.